We have investigated the regulation of the expression of two growth factors found in vascular smooth muscle, transforming growth factor a (TGFa) and basic fibroblast growth factor (bFGF). Cells cultured in medium containing 30 mM glucose exhibited a 2-fold increase in TGFa mRNA and a 3-fold increase in bFGF mRNA compared with cells grown in normal (5.5 mM) glucose. Glucosamine was more potent than glucose, leading to a 6-fold increase in TGFa mRNA. TGFa protein levels were also increased by glucosamine treatment, and the predominant species present was the membrane-bound precursor form of TGFa. To examine further the regulation of growth factors by sugars, cultured rat aortic smooth muscle cells were transfected with a plasmid construct consisting of a 1.2-kilobase-pair fragment of the TGFa promoter linked to a luciferase reporter gene. Increasing the concentration ofglucose in the culture medium from 5.5 mM to 30 mM led to a rapid, 1.7-fold increase in the activity of the TGFa promoter. Glucosamine was much more potent than glucose in this stimulation, with 2 mM gluamine causing a 12-fold increase in TGFa promoter activity. Insulin had no effect on luciferase activity in either the presence or the absence of added sugars. The glucose response element of the TGFa gene maps to a 130-base-pair segment that includes three potential binding sites for the transcription factor Spl. We conclude that high glucose concentrations such as are reached in diabetes mellitus can stimulate the transcription of the genes for growth factors in vascular smooth muscle cells. This signaling pathway apparently involves the metabolism of glucose to glucosamine. This effect could be representative of nutritional regulation of a family of genes and could contribute to the toxicity of hyperglycemia and the vascular complications of diabetes.
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Vascular smooth muscle cell proliferation is an early event in the pathogenesis of atherosclerosis, and growth factors have been hypothesized to play an important role in the control of this process (1) . For example, platelet-derived growth factor is expressed in atherosclerotic lesions and is found in macrophages in all phases ofthe development of those lesions (2) . Growth factors synthesized by the vascular smooth muscle cells themselves may also be involved in the pathogenesis of vascular disease. Thus, the exposure of vascular smooth muscle cells to growth factors could be determined by the plasma concentration of a growth factor, by delivery from blood-derived cells, or by the production rate of the growth factor by cells within the vessel wall. To examine whether the synthesis of growth factors might be sensitive to environmental conditions, we studied two growth factors known to be expressed in vascular smooth muscle cells, transforming growth factor a (TGFa; refs. 3 and 4) and basic fibroblast growth factor (bFGF; refs. 5 and 6). In addition, because the promoter for the TGFa gene has been cloned and characterized (7, 8) , we studied in more detail the transcriptional regulation of the TGFa gene. In other cells, the expression of TGFa has been shown to be regulated at both the transcriptional and the translational levels (4, 7), and the regions ofthe TGFa promoter that confer hormonal regulation have been identified (7) .
We show in this paper that the mRNAs for both TGFa and bFGF accumulate significantly in vascular smooth muscle cells exposed to high glucose concentrations. The Luciferase and Glucose Transport Assays. Luciferase activity was measured in detergent extracts of cells in the presence of ATP and luciferin in an LKB luminometer (7) .
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Background luminescence was subtracted from all readings and was <1% of the cell-specific readings. The assay was determined to be linear in a range ±2 orders of magnitude from the range in which measurements were made.
Hexose uptake was measured in confluent 35-mm dishes as described (10) After various times, the cells were rapidly rinsed three times in ice-cold saline and lysed in detergent for measurement of radioactivity by scintillation counting. In this assay system, the uptake of L-glucose is <1% of that observed with the D isomer. Northern Blotting and Immunoblotting. Early-passage rat aortic smooth muscle cells (five 10-cm dishes per condition) were treated with or without sugars for 3 days. Cell density was adjusted to achieve confluence at the end of the treatment period. Total RNA was isolated by acid guanidinium thiocyanate-phenol/chloroform extraction (11) . Poly(A)+ RNA was purified by chromatography on oligo(dT)-cellulose (12) and 5 pug was analyzed by electrophoresis in a 1% agarose/6% formaldehyde gel and Northern blotting on a nylon membrane (GeneScreen; NEN). The blot was probed with a labeled rat TGFa cDNA kindly provided by D. C. Lee (13) . The blots were subsequently stripped and reprobed with a cDNA sequence from (-actin (14) for purposes of data normalization, as well as a probe for bFGF (Scios, Mountain View, CA). Immunoblotting of cell extracts with an antibody specific for TGFa has been described (4).
RESULTS
Effects of Sugars on Levels of TGFa and bFGF mRNA in Rat Aortic Smooth Muscle Cells. To determine whether glucose regulated growth factor gene expression, we measured mRNA levels for TGFa and bFGF in rat smooth muscle cells. Cells were grown in normal medium (5.5 mM glucose) or in medium supplemented to 30 mM glucose for 3 days. Poly(A)+ RNA was prepared and analyzed by Northern blotting using a cDNA probe for the rat TGFa gene (13) and for bFGF. The levels of both TGFa and bFGF mRNA were regulated by glucose in the aortic cells (Fig. 1A) . TGFa mRNA was detectable in these cells and was increased roughly 2-fold (as measured by densitometric scanning) by glucose, whereas the mRNA for bFGF increased >3-fold. 3-Actin mRNA was not affected by glucose treatment and was used to normalize the values obtained by densitometric scanning (Fig. 1B) .
In at least one model of altered cellular regulation by high concentrations of glucose, the hexosamine pathway of glucose metabolism has been implicated (15) . We therefore also tested the effect of glucosamine on TGFa mRNA. Glucosamine (7.5 mM in the presence of 5 mM glucose) was more potent than 30 mM glucose, leading to a 6-fold increase in TGFa mRNA when normalized to the level of actin mRNA. To test the generality of these findings, bFGF was examined on the same blots and was found to increase 1.9-fold in response to glucosamine (data not shown).
Alterations in Levels of TGFa Protein in Treated Cells. To confirm that the increased levels of mRNA for TGFa led to increases in the level of the growth factor itself, extracts of cells and media from cells cultured with glucosamine were subjected to immunoblotting using an antibody to TGFa. Glucosamine treatment did lead to an increase in immunoreactive TGFa (Fig. 2 ). This TGFa is in the form of a cell-associated, 20-kDa species that represents the uncleaved, membrane-anchored growth factor precursor (4) . This increase in TGFa was -4-fold, as determined by densitometric scanning of the autoradiogram and normalizing the density to total protein levels measured on a comparably run Coomassie blue-stained gel. Immunoblotting of concentrates of cell supernatants failed to reveal soluble TGFa (5 Northern blotting using a labeled rat TGFa cDNA probe (13). The blots were subsequently stripped and reprobed using a 1.6-kilobase cDNA sequence from P-actin and bFGF (14) control or treated cells, and we conclude that most of the TGFa made in these cultured vascular cells is not processed to its soluble form.
Effects muscle cells were transfected with an expression vector in which 1.2 kilobases ofthe 5' flanking region ofthe TGFa gene had been subcloned upstream of the luciferase gene (Fig. 3 Inset). This construct has been shown to contain the elements that confer proper initiation and hormone responsiveness of TGFa transcription (7) . Transfected cells were cultured in unmodified medium (5.5 mM D-glucose) and an additional 25 mM D-glucose was added at various times before assay of luciferase activity. All assays were done 4 days after the electroporation. Glucose caused a rapid and significant increase in the transcription of the TGFa-luciferase construct. Stimulation was evident with as little as 30 min exposure to 30 mM glucose and was half-maximal after -4 hr in the high-glucose medium (Fig. 3) .
We also examined the effects of other sugars, particularly glucosamine, and as was the case for mRNA levels, glucosamine was much more potent than glucose in stimulating activity of the TGFa-luciferase construct (Fig. 4) . Compared with control cells cultured in 5 mM D-glucose, 5 mM and 10 mM D-glucosamine led to 2.7-and 5.9-fold stimulations of TGFa transcription. D-Glucose at 20 or 30 mM stimulated 1.9-fold. These values agree very well with the stimulation of native mRNA levels and validate the use of the reporter construct to study TGFa regulation. L-Glucose at 30 mM had no effect on the activity of the TGFa-luciferase construct, indicating that the activation of transcription is not a consequence of osmolality. Insulin has no effect on TGFa promoter activity in these cells, either by itself or in combination with the sugars (Fig. 4A) .
The relative potencies of glucose and glucosamine are shown in Fig. 4B . In these experiments and unlike those in order to examine the effects of glucose over a fuller range of concentrations. The final concentration of glucose in the basal medium was actually 1.5 mM due to the presence of 10%o nondialyzed FBS in the medium. The medium was supplemented with pyruvate (0.15 mM) as an energy source, and in this medium cells were able to proliferate at 87% of the rate seen in the high-glucose cultures. Glucose caused a 2.3-fold stimulation of TGFa transcription, with halfmaximal stimulation seen at -6 mM glucose. When cells were cultured in 2.5 mM glucose, glucosamine caused a 12-fold stimulation that was half-maximal at 1-2 mM. When cultured in higher-glucose medium (5 mM), the effects of glucosamine were diminished, with 6-fold stimulation seen that was half-maximal at 5 mM glucosamine. The kinetics of glucosamine stimulation of TGFa expression were similar to those observed for glucose, and glucosamine treatment had no significant effect on cell protein measured in the cell lysates at the end of the experiment (data not shown).
To explore further the relative potencies of glucose and glucosamine in activating the TGFa promoter, we determined the actual rates of transport for 2-deoxyglucose and glucosamine in these cells. The uptake of 2-deoxyglucose and glucosamine is linear for at least 5 min (data not shown), and over this time period uptake rates correlate very well with true transport rates (16) . The uptake rate of glucosamine was 13% of that seen for 2-deoxyglucose (0.18 amol per cell per min, Km = 10.5 ± 1.5 mM, for glucosamine, vs. 1.35 amol per cell per min, Km = 3.5 + 1.5 mM, for 2-deoxyglucose). These data, combined with the dose-response analysis above, suggest that intracellular glucosamine is 50-to 1(K)fold more potent than glucose in stimulating activity of the TGFaProc. Natl. Acad Sci. USA 89 (1992) .1 luciferase construct. Insulin had no discernable effect on the uptake rate for either sugar. Glucose and glucosamine probably compete for the same transport system, since each inhibits the uptake of the other competitively (data not shown). This competition for transport most likely explains the diminished effect of glucosamine observed in the presence of higher glucose concentrations (Fig. 4B) .
Mapping of the Glucose-and Glucosamine-Responsive Elements of the TGFa Gene. To identify the elements that respond to sugars in the TGFa promoter region, various TGFa-luciferase constructs containing portions of the TGFa 5' flanking region were transfected into rat aortic smooth muscle cells. The cells were cultured in 5 mM glucose with or without 5 mM glucosamine for 3 days and the luciferase activity was assayed. Glucosamine responsiveness was conferred by a 130-base-pair (bp) segment of the TGFa 5' flanking region (bp -373 to -242) cloned upstream of the thymidine kinase promoter (Fig. 5) . This same 130-bp region has been shown also to contain the regulatory elements of the TGFa promoter that respond to protein kinase C and to TGFa itself (7). Glucosamine had no significant effect on the thymidine kinase promoter by itself, further confirming the specificity of the glucosamine effect.
DISCUSSION
We have investigated the regulation of two growth factors found in vascular smooth muscle, TGFa and bFGF, and shown that levels of their mRNAs are increased by glucose. These changes in TGFa mRNA were paralleled by increases in TGFa protein. Constructs with the TGFa promoter upstream of a reporter gene were used to study this regulation in greater detail. Stimulation of TGFa promoter activity was seen at concentrations of glucose that occur in the blood and reached a maximum at 20-30 mM. This plateau is most likely due to the saturation of the glucose transport system at these glucose concentrations, consistent with our preliminary measurement of the Km for 2-deoxy-D-glucose transport in these cells (2-5 mM; data not shown) and similar measurements by others (17) .
There is substantial evidence that abnormal proliferation of smooth muscle cells in the arterial wall is associated with atherosclerosis and may even precede and cause the lipid accumulation characteristic of the atherosclerotic lesions seen in Western societies (1) . It is presumed that this proliferation is mediated by growth factors, and indeed platelet-derived growth factor is found at high levels in atherosclerotic lesions (2) . bFGF has also been implicated in atherogenesis (5, 6) . (7); in the lower two constructs the herpes simplex thymidine kinase (TK) promoter has been substituted for the region (bp -242 to -59) that contains that site. After poration the cells were exposed to 5 mM glucose with or without 5 mM glucosamine for 3 atherogenesis. TGFa is normally found in arterioles (4) and is mitogenic for the arterial endothelium (18) (26) , that do exhibit biologic activities toward vascular cells (27) . Insulin did not, however, affect the transcription of TGFa in the aortic smooth muscle cells. These cells do not express significant amounts of the insulin-stimulable glucose transporter, GLUT4 (28) , so insulin would also not have been expected to augment TGFa transcription indirectly by facilitating glucose entry into the cells.
Glucosamine was strikingly more potent than glucose in stimulating TGFa promoter activity. Not only did it cause stimulation at lower concentrations but it also stimulated to a greater degree than did glucose. Intracellular glucosamine is likely to be on the order of 100 times as potent as glucose, given that glucosamine added extracellularly is more potent despite the fact that the transport rate for glucosamine is lower than that for glucose. One possible explanation for the potency of glucosamine in our system is that glucose and glucosamine are stimulating TGFa gene expression through a common pathway by which a small portion of intracellular glucose is metabolized to glucosamine.
The chief metabolic pathway involving glucosamine is the hexosamine synthetic pathway, and this pathway has been hypothesized to account for the induction of insulin resistance by glucose and glucosamine in adipocytes (15) . In the hexosamine biosynthetic pathway, fructose 6-phosphate is first converted to glucosamine 6-phosphate by the ratelimiting enzyme glutamine:fructose-6-phosphate amidotransferase (GFA; EC 2.6.1.16); glucosamine 6-phosphate is subsequently metabolized to UDP-N-acetyl-sugars used in the biosynthesis of glycoproteins. Both GFA and the indtiction of insulin resistance require glutamine and are sensitive to azaserine (15) . Involvement of this pathway also explains the increased potency of glucosamine compared with glucose: glucosamine is efficiently phosphorylated by hexokinase (29) and therefore bypasses the rate-limiting step, catalyzed by GFA, in the conversion of glucose to glucosamine. We favor the hypothesis that glucose and glucosamine are acting through a common (e.g., hexosamine) pathway, and there is as yet no indication that the effects of glucose and glucosamine can be independently modulated. If overexpression of GFA activity were found to minmick the effects of glucose on TGFa levels, that finding would provide strong support for this hypothesis. The gene for GFA from Saccharomyces cerevisiae has been cloned (30), and we have replicated that cloning. This gene, when overexpressed in the aortic smooth muscle cells, does lead to a glucose-sensitive up-regulation in TGFa transcriptional activity in a manner fully consistent with the present data and hypothesis above (unpublished work).
Protein kinase C (PKC) is known to modulate the transcription of several growth factors including TGFa (31) . Activation of PKC has also been hypothesized to play a role in glucose toxicity and the mediation of complications in diabetes. This is based on the observations that PKC activity is induced in cells exposed to high concentrations of glucose, possibly through the increased accumulation of diacylglycerol, an activator of PKC (32) (33) (34) . We have found, however, that in these cells phorbol ester stimulates TGFa promoter activity minimally compared with the stimulation by sugar (data not shown). Furthermore, treatment of the cells chronically with phorbol to down-regulate PKC, or treatment with staurosporine to inhibit PKC, did not affect the ability of glucose or glucosamine to activate the TGFa promoter. This suggests that the hexosamine pathway does not require PKC for the stimulation of TGFa transcription.
Glucosamine 6-phosphate is further metabolized to UDP-N-acetyl-sugars, so protein glycosylation may play a role in the regulation of gene transcription by this pathway. Interestingly, glycosylation does affect the expression of the glucoseregulated proteins Grp78 and Grp94, which are induced both by hypoglycemia. and by treatment with tunicamycin (35) . These proteins are highly homologous to heat shock proteins of similar size, and they might act as negative regulators of growth factor gene expression. Alternatively, glycosylation could serve in a more general but as yet undefined way to regulate gene transcription. Interestingly, a number of nuclear proteins (36) and transcription factors, including Spl (37), are glycoproteins, predominantly modified by the addition of O-linked N-acetylglucosamine. The 130-bp region of the TGFa gene that contains the glucose response element includes three binding sites for the transcription factor Spl (unpublished work). Glucose did not cause an appreciable increase in the level of Spl mRNA, although glucosamine treatment did lead to a small (50%1) increase in Spl mRNA (data not shown). Thus, the increased activity of the TGFa promoter is unlikely to be simply explained by increased levels of this transcription factor and is more likely to be explained by modifications of transcription factors that affect their activity or subcellular distribution (38) . It should be pointed out that the 130-bp region of the TGFa gene is G+C-rich and aside from the Spl sites is otherwise unremarkable. Such regions are common in "housekeeping" genes but have also been found in the promoters of genes such as the insulin, epidermal growth factor receptor, and c-myc genes. It may be that the observed regulation oftranscription by glucose will be found in other genes.
In summary, our results demonstrate that glucose can regulate the expression of at least two growth factors that are potential mediators of atherosclerosis. While these are almost certainly not the sole factors involved in the vascular complications of diabetes, the study of the mechanisms by which sugars modulate gene expression is likely to be of general relevance both to normal and abnormal physiology.
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